These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 16388966

  • 1. Peroxisome proliferator-activated receptor gamma in malignant diseases.
    Wang T, Xu J, Yu X, Yang R, Han ZC.
    Crit Rev Oncol Hematol; 2006 Apr; 58(1):1-14. PubMed ID: 16388966
    [Abstract] [Full Text] [Related]

  • 2. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells.
    Subbarayan V, Sabichi AL, Kim J, Llansa N, Logothetis CJ, Lippman SM, Menter DG.
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1710-6. PubMed ID: 15533897
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
    Abdelrahman M, Sivarajah A, Thiemermann C.
    Cardiovasc Res; 2005 Mar 01; 65(4):772-81. PubMed ID: 15721857
    [Abstract] [Full Text] [Related]

  • 4. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma.
    Zieleniak A, Wójcik M, Woźniak LA.
    Arch Immunol Ther Exp (Warsz); 2008 Mar 01; 56(5):331-45. PubMed ID: 18836859
    [Abstract] [Full Text] [Related]

  • 5. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W.
    Pharmacol Rev; 2006 Dec 01; 58(4):726-41. PubMed ID: 17132851
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM, Schiffrin EL.
    Vascul Pharmacol; 2006 Jul 01; 45(1):19-28. PubMed ID: 16782410
    [Abstract] [Full Text] [Related]

  • 7. Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen.
    Bernardo A, Ajmone-Cat MA, Gasparini L, Ongini E, Minghetti L.
    J Neurochem; 2005 Feb 01; 92(4):895-903. PubMed ID: 15686492
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
    Han S, Roman J.
    Anticancer Drugs; 2007 Mar 01; 18(3):237-44. PubMed ID: 17264754
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J, Sterz J, Krebbel H, Zavrski I, Kaiser M, Zang C, Heider U, Jakob C, Elstner E, Sezer O.
    Anticancer Drugs; 2006 Aug 01; 17(7):763-9. PubMed ID: 16926626
    [Abstract] [Full Text] [Related]

  • 10. Proteasome inhibitors induce peroxisome proliferator-activated receptor transactivation through RXR accumulation and a protein kinase C-dependent pathway.
    Tsao WC, Wu HM, Chi KH, Chang YH, Lin WW.
    Exp Cell Res; 2005 Mar 10; 304(1):234-43. PubMed ID: 15707588
    [Abstract] [Full Text] [Related]

  • 11. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D, Yoshihiro H, Nakanishi M, Naruyama H, Okada S, Ando R, Tozawa K, Kohri K.
    Cancer Detect Prev; 2008 Mar 10; 32(3):259-66. PubMed ID: 18789607
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury.
    Cuzzocrea S.
    Vascul Pharmacol; 2004 Jul 10; 41(6):187-95. PubMed ID: 15653094
    [Abstract] [Full Text] [Related]

  • 13. Novel PPAR-gamma agonists identified from a natural product library: a virtual screening, induced-fit docking and biological assay study.
    Salam NK, Huang TH, Kota BP, Kim MS, Li Y, Hibbs DE.
    Chem Biol Drug Des; 2008 Jan 10; 71(1):57-70. PubMed ID: 18086153
    [Abstract] [Full Text] [Related]

  • 14. A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplastic effect of iodine in mammary cancer.
    Nuñez-Anita RE, Arroyo-Helguera O, Cajero-Juárez M, López-Bojorquez L, Aceves C.
    Prostaglandins Other Lipid Mediat; 2009 Jun 10; 89(1-2):34-42. PubMed ID: 19443248
    [Abstract] [Full Text] [Related]

  • 15. Evidence for differential effects of glucose and cycloheximide on mRNA levels of peroxisome proliferator-activated receptor- (PPAR-) machinery members: Superinduction of PPAR-gamma1 and -gamma2 mRNAs.
    Rypka M, Veselý J.
    Acta Biochim Pol; 2010 Jun 10; 57(2):209-15. PubMed ID: 20563322
    [Abstract] [Full Text] [Related]

  • 16. Dietary modulation of peroxisome proliferator-activated receptor gamma.
    Marion-Letellier R, Déchelotte P, Iacucci M, Ghosh S.
    Gut; 2009 Apr 10; 58(4):586-93. PubMed ID: 19017686
    [Abstract] [Full Text] [Related]

  • 17. Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes.
    Tan NS, Michalik L, Desvergne B, Wahli W.
    J Steroid Biochem Mol Biol; 2005 Feb 10; 93(2-5):99-105. PubMed ID: 15860251
    [Abstract] [Full Text] [Related]

  • 18. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells.
    Zheng S, Chen A.
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan 10; 292(1):G113-23. PubMed ID: 16959952
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C, Katsamangou E, Tsourouflis G, Zizi-Serbetzoglou D, Kouraklis G, Theocharis S.
    Med Sci Monit; 2009 May 10; 15(5):BR148-56. PubMed ID: 19396032
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ, Liu PQ, Lin DJ, Xiao RZ, Huang M, Li XD, He Y, Huang RW.
    Ann Hematol; 2007 Mar 10; 86(3):173-83. PubMed ID: 17089125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.